Wall Street Beat
iRadimed raises the bar with $12.6M IPO
iRadimed launched its initial public offering today in hopes of raising $12.6 million for its non-magnetic infusion pumps.
The Florida-based device maker is offering just over 2 million shares at $6.25 apiece, as well as an additional 302,400 shares, worth about $1.9 million before underwriting discounts and commissions, to cover potential over-allotments.
Abbott reports meager medical device sales growth despite Q2 beats
Analyst: St. Jude Medical’s Q2 results could signal ICD rebound
Pharma delivers another beat & raise quarter for Johnson & Johnson
Abbott to deal pharma line to Mylan for $5.3B
Allergan renews fight against hostile Valeant takeover
Intersect ENT sets terms for $65M IPO
Intersect ENT said today that it hopes to raise as much as $65 million in an initial public offering of 5 million shares.
Ocular Therapeutix sets terms for IPO
Ocular Therapeutix is looking to raise as much as $80 million in a forthcoming initial public offering, the company said today.
Bedford, Mass.-based Ocular Therapeutix said it plans to offer 5 million shares at $14 to $16 apiece, making the IPO worth $70 million to $80 million.
Exo-suit maker ReWalk files for $57.5M IPO
ReWalk Robotics, formerly Argo Medical Technologies, is preparing an initial public offering worth up to $57.5 million, according to regulatory filings.